![The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/3188c36b-9a69-4509-9116-c8797795272b/gr1.gif)
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet
![Everything you need to know about sodium valproate and other antiepileptic drugs in pregnancy - The Pharmaceutical Journal Everything you need to know about sodium valproate and other antiepileptic drugs in pregnancy - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2022/05/Why-is-valproate-still-being-prescribed-in-pregnant-women_AL22-1.jpg)
Everything you need to know about sodium valproate and other antiepileptic drugs in pregnancy - The Pharmaceutical Journal
![Frontiers | Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients Frontiers | Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients](https://www.frontiersin.org/files/MyHome%20Article%20Library/549819/549819_Thumb_400.jpg)
Frontiers | Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients
![Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: A retrospective database review - ScienceDirect Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: A retrospective database review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641120303659-ga1.jpg)
Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: A retrospective database review - ScienceDirect
Epilepsy Society - Following the publication of the Independent Medicines and Medical Devices Safety Review into sodium valproate (also known as Epilim, Epival, Episenta, Convulex and Depakote) we've heard from many people
![Sodium valproate dose was gradually reduced to 400mg daily in mid-March... | Download Scientific Diagram Sodium valproate dose was gradually reduced to 400mg daily in mid-March... | Download Scientific Diagram](https://www.researchgate.net/publication/265730589/figure/fig1/AS:269534720425989@1441273493580/Sodium-valproate-dose-was-gradually-reduced-to-400mg-daily-in-mid-March-2013-because-she.png)